FlandersBio on Twitter

Biotech company Ablynx wins European Mediscience Award: http://tiny.cc/knen6

Follow us on Twitter

Life Sciences Database

Databank Biowetenschappen

in het nederlands in english

FlandersBio offers an up-to-date life sciences database containing all the life sciences companies with biotech activity in Flanders, and all FlandersBio members. The guide provides easy and fast access to the local life sciences community.

FlandersBio beschikt over een geüpdate databank met een overzicht van de Vlaamse bedrijven met biotechactiviteit en alle FlandersBio-leden. De databank verleent een makkelijke en vlugge toegang tot de lokale biowetenschappen-gemeenschap.

PharmaNeuroBoost

Website: http://www.pharmaneuroboost.com
Email:
Phone: +32 11 48 07 50
FlandersBio Member
More address details

Business Focus

The company’s primary goal is to significantly improve current therapy targeted against mood and anxiety disorders. The two front-running proprietary projects (PNB01 and PNB02) are targeted against depression and schizophrenia, respectively.

Tags

Company Profile

The company is organized through an innovative business concept. It is managed by an experienced management team and has complete and experienced project teams and sub-teams installed, moving its development projects forward in an expedited and high-quality manner. Predefined trials and sub-projects are executed by validated CROs and strategic partners. Headquarters are located in Alken, Belgium.

Science & Technology or Services

PNB’ lead programs are PNB01 and PNB02.

PNB01 is a combination of Low-Dose Pipamperone, PNB’ propriety asset, and the antidepressant Citalopram. Preliminary clinical data suggest that PNB01 has a higher response rate with regard to symptom reduction in depression than currently marketed antidepressants. The onset of action is significantly faster and it is generally well tolerated.

The second program is the combination of Low-Dose Pipamperone and atypical antipsychotics (AP’s). Current AP’s have low to moderate efficacy, with a high burden of adverse events. PNB02 mimics the receptor occupancy profile of the first in class antipsychotic Clozapine, without the unwanted high antagonism towards the histaminergic and acetylcholine muscarinic receptors responsible for important adverse events.

Alliances

PNB has already established R&D co-operations with several national and international partners i.e.

  • Anima Research Center, Alken (BE)
  • Emory University, Atlanta (US)
  • Procela Consultants, Dublin (IRE)
  • Kinesis Pharma, Breda (The Netherlands)
  • NOTOX, 's-Hertogenbosch (The Netherlands)
  • ABL, Assen (The Netherlands)
  • CPSResearch, Glasgow (UK)
  • Robertson Centre, Glasgow University (UK)
  • UGhent, Ghent (BE)

More info

Address: Alkerstraat 30A
3570 Alken
Belgium

Route: Via Google Maps
Website: http://www.pharmaneuroboost.com

Phone: +32 11 48 07 50
Fax: +32 11 48 49 23
Foundation date: 2006
Email:

Location on a Map

Sorry, to find this company's location on Google Maps, Javascript is required.

Become a Member

Discover the 13 reasons to become a FlandersBio member and join our extensive life sciences network.

Read more

FlandersBio Members

LifetecVision XiTechniX DS Fibres Genzyme Flanders ALHO Systeembouw The Tallent Gallery SAS Institute Egemin Consulting BioActor unithink Roche Diagnostics Belgium Qarad K.U.Leuven - BioSCENTer ReGenesys Pepric Vrije Universiteit Brussel Arcom Scientific UGent Flanders Investment & Trade Bird & Bird Hasselt University Okapi Sciences SEPS Pharma Aon Belgium Korn/Ferry Futurestep Quantum Management & Consulting PharmaNeuroBoost Intellicrops

View all members

Life Sciences Map

Life Sciences Map

View Life Sciences Map

Back to top

Print